Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001457612-21-000102
Filing Date
2021-10-28
Accepted
2021-10-28 16:07:05
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gnca-20210930.htm   iXBRL 10-Q 1155811
2 EX-31.1 a2021q3ex311.htm EX-31.1 11826
3 EX-31.2 a2021q3ex312.htm EX-31.2 11468
4 EX-32 a2021q3ex32.htm EX-32 9285
10 gnca-20210930_g1.jpg GRAPHIC 16581
  Complete submission text file 0001457612-21-000102.txt   5808182

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gnca-20210930.xsd EX-101.SCH 35606
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gnca-20210930_cal.xml EX-101.CAL 46441
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gnca-20210930_def.xml EX-101.DEF 218986
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gnca-20210930_lab.xml EX-101.LAB 513321
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gnca-20210930_pre.xml EX-101.PRE 362402
11 EXTRACTED XBRL INSTANCE DOCUMENT gnca-20210930_htm.xml XML 940599
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

EIN.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36289 | Film No.: 211358264
SIC: 2836 Biological Products, (No Diagnostic Substances)